91 related articles for article (PubMed ID: 1334800)
1. Derivatives of 1-beta-D-ribofuranosylbenzimidazole 3',5'-phosphate that mimic the actions of adenosine 3',5'-phosphate (cAMP) and guanosine 3',5'-phosphate (cGMP).
Genieser HG; Winkler E; Butt E; Zorn M; Schulz S; Iwitzki F; Störmann R; Jastorff B; Døskeland SO; Ogreid D
Carbohydr Res; 1992 Oct; 234():217-35. PubMed ID: 1334800
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Sp-5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole- 3',5'-monophosphorothioate (Sp-5,6-DCl-cBiMPS) as a potent and specific activator of cyclic-AMP-dependent protein kinase in cell extracts and intact cells.
Sandberg M; Butt E; Nolte C; Fischer L; Halbrügge M; Beltman J; Jahnsen T; Genieser HG; Jastorff B; Walter U
Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):521-7. PubMed ID: 1659381
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells.
Whalin ME; Scammell JG; Strada SJ; Thompson WJ
Mol Pharmacol; 1991 Jun; 39(6):711-7. PubMed ID: 1646946
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and enzymic activity of 8-acyl and 8-alkyl derivatives of guanosine 3, 5-cyclic phosphate.
Christensen LF; Meyer RB; Miller JP; Simon LN; Robins RK
Biochemistry; 1975 Apr; 14(7):1490-6. PubMed ID: 235954
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the functional role of cGMP-dependent protein kinase in intact human platelets using a specific activator 8-para-chlorophenylthio-cGMP.
Butt E; Nolte C; Schulz S; Beltman J; Beavo JA; Jastorff B; Walter U
Biochem Pharmacol; 1992 Jun; 43(12):2591-600. PubMed ID: 1321624
[TBL] [Abstract][Full Text] [Related]
6. Rp diastereomeric analogs of cAMP inhibit both cAMP- and cGMP-induced dilation of hamster mesenteric small arteries.
Jackson WF
Pharmacology; 1996 Apr; 52(4):226-34. PubMed ID: 8841085
[TBL] [Abstract][Full Text] [Related]
7. Binding of adenosine 3',5'-monophosphate dependent protein kinase regulatory subunit to immobilized cyclic nucleotide derivatives.
Dills WL; Beavo JA; Bechtel PJ; Myers KR; Sakai LJ; Krebs EG
Biochemistry; 1976 Aug; 15(17):3724-31. PubMed ID: 182216
[TBL] [Abstract][Full Text] [Related]
8. Substrate and effector specificity of a guanosine 3':5'-monophosphate phosphodiesterase from rat liver.
Moss J; Manganiello VC; Vaughan M
J Biol Chem; 1977 Aug; 252(15):5211-5. PubMed ID: 195942
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibition of mesangial MAP kinase cascade by cyclic nucleotides.
Haneda M; Araki S; Sugimoto T; Togawa M; Koya D; Kikkawa R
Kidney Int; 1996 Aug; 50(2):384-91. PubMed ID: 8840264
[TBL] [Abstract][Full Text] [Related]
10. Hydrolysis of cyclic nucleotides by a purified cGMP-stimulated phosphodiesterase: structural requirements for hydrolysis.
Braumann T; Erneux C; Petridis G; Stohrer WD; Jastorff B
Biochim Biophys Acta; 1986 Jun; 871(2):199-206. PubMed ID: 3011099
[TBL] [Abstract][Full Text] [Related]
11. Different effects of cAMP and cGMP derivatives on the activity of an identified neuron: biochemical and electrophysiological analysis.
Levitan IB; Norman J
Brain Res; 1980 Apr; 187(2):415-29. PubMed ID: 6154497
[TBL] [Abstract][Full Text] [Related]
12. Sp-5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole-3',5'-cyclic monophosphorothioate is a potent stimulus for insulin release.
Laychock SG
Endocr Res; 1993; 19(2-3):113-22. PubMed ID: 8287829
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP.
Cornwell TL; Arnold E; Boerth NJ; Lincoln TM
Am J Physiol; 1994 Nov; 267(5 Pt 1):C1405-13. PubMed ID: 7977701
[TBL] [Abstract][Full Text] [Related]
14. Cardiac cGMP-stimulated cyclic nucleotide phosphodiesterases: effects of cGMP analogues and drugs.
Komas N; Le Bec A; Stoclet JC; Lugnier C
Eur J Pharmacol; 1991 Jan; 206(1):5-13. PubMed ID: 1648496
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPS.
Butt E; Pöhler D; Genieser HG; Huggins JP; Bucher B
Br J Pharmacol; 1995 Dec; 116(8):3110-6. PubMed ID: 8719784
[TBL] [Abstract][Full Text] [Related]
16. Adrenal steroidogenic actions of cyclic nucleotide derivatives in the rat.
Free CA; Paik VS
Endocrinology; 1977 May; 100(5):1287-93. PubMed ID: 191239
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of testosterone production by atrial natriuretic peptide in isolated mouse Leydig cells results from a promiscuous activation of cyclic AMP-dependent protein kinase by cyclic GMP.
Schumacher H; Müller D; Mukhopadhyay AK
Mol Cell Endocrinol; 1992 Dec; 90(1):47-52. PubMed ID: 1284496
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the hyperpolarization-activated current (Ih) by cyclic nucleotides in guinea-pig primary afferent neurons.
Ingram SL; Williams JT
J Physiol; 1996 Apr; 492 ( Pt 1)(Pt 1):97-106. PubMed ID: 8730586
[TBL] [Abstract][Full Text] [Related]
19. Specificity of cyclic GMP activation of a multi-substrate cyclic nucleotide phosphodiesterase from rat liver.
Erneux C; Couchie D; Dumont JE; Baraniak J; Stec WJ; Abbad EG; Petridis G; Jastorff B
Eur J Biochem; 1981 Apr; 115(3):503-10. PubMed ID: 6263632
[TBL] [Abstract][Full Text] [Related]
20. Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood platelets.
Herfindal L; Nygaard G; Kopperud R; Krakstad C; Døskeland SO; Selheim F
Biochem Biophys Res Commun; 2013 Aug; 437(4):603-8. PubMed ID: 23850619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
